In Vitro Susceptibility of Methicillin-Resistant Staphylococcus aureus to Ceftaroline: A Prospective Observational Study From a Tertiary Care Hospital in North India. [PDF]
Jain G +7 more
europepmc +1 more source
Antimicrobial Resistance in Major Gram-Positive Pathogens: Beyond the Vancomycin Border. [PDF]
Papageorgiou D, Akinosoglou K.
europepmc +1 more source
OBJECTIVES: There are few convenient intravenous options for long-term outpatient treatment of osteoarticular infection (OAI) and limited effectiveness and safety data exist for this off-label use of ceftaroline.
Davis, Susan L +3 more
core
Stewardship Challenges, PK/PD Evidence, and Prescribing Appropriateness for Recently Approved Antibiotics in Pediatric Practice. [PDF]
Romandini A +8 more
europepmc +1 more source
Antibiotic-associated adverse events in bone and joint infections: a FAERS pharmacovigilance study. [PDF]
Dai H, Li H, Xiao C.
europepmc +1 more source
Nontuberculous Mycobacterial Infections at a National Cancer Institute-Designated Comprehensive Cancer Center in Florida. [PDF]
Pasikhova Y +5 more
europepmc +1 more source
Plasma and parasternal subcutaneous tissue pharmacokinetics of ceftaroline fosamil in cardiac surgery with cardiopulmonary bypass. [PDF]
Edlinger-Stanger M +5 more
europepmc +1 more source
Clinical Experience of Ceftaroline Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational Study. [PDF]
Arnés-García D +5 more
europepmc +1 more source
<i>Staphylococcus pettenkoferi</i>: an underrecognized species with clinically relevant antimicrobial resistance. A comprehensive genomic European study. [PDF]
Magnan C +16 more
europepmc +1 more source
Daptomycin failure in the treatment of Enterococcus faecium bacteremia: microbiological insights and the importance of dual therapy including beta-lactam. [PDF]
Luque Paz D, Tattevin P.
europepmc +1 more source

